Neupro and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Neupro (rotigotine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Azilect, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Heart attack when taking Neupro. It is created by eHealthMe based on reports of 11,313 people who have side effects when taking Neupro from the FDA, and is updated regularly.

What is Neupro?

Neupro has active ingredients of rotigotine. It is often used in parkinson's disease. eHealthMe is studying from 11,393 Neupro users. Check the latest studies of Neupro.

What is Heart attack?

Heart attack is found to be associated with 2,475 drugs and 3,298 conditions by eHealthMe. Check the latest studies of Heart attack.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

11,313 people reported to have side effects when taking Neupro.
Among them, 48 people (0.42%) have Heart attack.

Among these 48 people:

How long have people been on Neupro when they have Heart attack? *

What is the gender of people who have Heart attack when taking Neupro? *

female: 31.25 %
male: 68.75 %

What is the age of people who have Heart attack when taking Neupro? *

What are other drugs people take besides Neupro? *

What are other side effects people have besides Heart attack? *

Pneumonia: 7 people, 14.58%
Nausea (feeling of having an urge to vomit): 5 people, 10.42%
Dyskinesia (abnormality or impairment of voluntary movement): 5 people, 10.42%
Weakness: 5 people, 10.42%
Fall: 4 people, 8.33%
Confusional State: 4 people, 8.33%
Cardiac Arrest: 4 people, 8.33%
Dyspnea (difficult or laboured breathing): 4 people, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 6.25%
Arrhythmias (irregular heartbeat): 3 people, 6.25%

What are the existing conditions these people have? *

High Blood Cholesterol: 8 people, 16.67%
High Blood Pressure: 5 people, 10.42%
Muscle Rigidity (muscle stiffness): 3 people, 6.25%
Diabetes: 3 people, 6.25%
Sleep Disorder: 2 people, 4.17%
Gastric Ulcer (stomach ulcer): 2 people, 4.17%
Seasonal Allergy (allergic condition due to certain season): 2 people, 4.17%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 4.17%
Migraine (headache): 2 people, 4.17%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Neupro and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neupro:

Neupro (11,393 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

Browse all side effects of Neupro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,475 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,298 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rotigotine (the active ingredients of Neupro) and Neupro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.